clinical trials

Deserted by Astellas and Merck, little Correvio still can't win over FDA panel concerned with its AFib drug's safety
Deserted by Astellas and Merck, little Correvio still can't win over FDA panel concerned with its AFib drug's safety
Endpoints
Correvio
Astellas
Merck
clinical trials
atrial fibrillation
Vernakalant
Brinavess
Flag link:
Vedanta Biosciences initiates first-in-patient study of VE800 in combination with Bristol-Myers Squibb’s Opdivo
Vedanta Biosciences initiates first-in-patient study of VE800 in combination with Bristol-Myers Squibb’s Opdivo
Pharmaceutical Business Review
Vedanta Biosciences
VE800
Bristol-Myers Squibb
Opdivo
cancer
clinical trials
Flag link:
ASH: Sanofi eyes FDA filing as orphan blood drug hits late-phase goal
ASH: Sanofi eyes FDA filing as orphan blood drug hits late-phase goal
Fierce Biotech
Sanofi
clinical trials
sutimlimab
ASH2019
cold agglutinin disease
Flag link:
Grifols says trial shows positive effects in slowing Alzheimer's
Grifols says trial shows positive effects in slowing Alzheimer's
Reuters
Grifols
Alzheimer's disease
clinical trials
Flag link:
With EMA review in progress, Novartis unveils more positive data on asthma therapy
With EMA review in progress, Novartis unveils more positive data on asthma therapy
Endpoints
Novartis
EMA
asthma
QMF149
clinical trials
Flag link:
FerGene’s Bladder Cancer Phase III Trial Hits Its Mark
FerGene’s Bladder Cancer Phase III Trial Hits Its Mark
BioSpace
FerGene
gene therapy
bladder cancer
NMIBC
Ferring Pharmaceuticals
Blackstone Life Sciences
clinical trials
Flag link:
The clearest picture of Biogen's Alzheimer's drug is still fuzzy
The clearest picture of Biogen's Alzheimer's drug is still fuzzy
Biopharma Dive
Biogen
Alzheimer's disease
clinical trials
aducanumab
Flag link:
New Biogen data showed no major safety issues for its Alzheimer's drug
New Biogen data showed no major safety issues for its Alzheimer's drug
Reuters
Biogen
safety
Alzheimer's disease
aducanumab
clinical trials
Flag link:
Novartis says mid-stage pipeline is setting up strong growth spurt
Novartis says mid-stage pipeline is setting up strong growth spurt
Pharmaforum
Novartis
Pharma CEOs
Vas Narasimhan
R&D
clinical trials
Flag link:
Sage Therapeutics Depression Drug Fails in Phase 3, Shares Fall 60%
Sage Therapeutics Depression Drug Fails in Phase 3, Shares Fall 60%
Xconomy
SAGE Therapeutics
clinical trials
SAGE-217
major depressive disorder
Flag link:
Aurinia’s drug to treat autoimmune kidney disease hits its goals in late-stage trial
Aurinia’s drug to treat autoimmune kidney disease hits its goals in late-stage trial
Stat
Aurinia Pharmaceuticals
lupus nephritis
clinical trials
voclosporin
autoimmune kidney disease
Flag link:
What to watch as Biogen presents its all-important Alzheimer's data
What to watch as Biogen presents its all-important Alzheimer's data
Biopharma Dive
Biogen
clinical trials
Alzheimer's disease
aducanumab
Flag link:
A clinical trial for Huntington’s opens the door to hope for some patients. Only so many can get in
A clinical trial for Huntington’s opens the door to hope for some patients. Only so many can get in
Stat
Huntington's disease
clinical trials
patients
Flag link:
Omeros hits endpoint in pivotal stem cell transplant study
Omeros hits endpoint in pivotal stem cell transplant study
Fierce Biotech
Omeros
narsoplimab
stem cells
stem cell transplant
clinical trials
Flag link:
Ardelyx's kidney disease drug hits goal in phase 3, teeing it up for FDA filing
Ardelyx's kidney disease drug hits goal in phase 3, teeing it up for FDA filing
Fierce Biotech
Ardelyx
chronic kidney disease
tenapanor
clinical trials
Flag link:
Digital Health Trial Uses AI For Better Epilepsy Treatment Decisions
Digital Health Trial Uses AI For Better Epilepsy Treatment Decisions
Forbes
epilepsy
clinical trials
artificial intelligence
digital health
Flag link:
Deep 6 AI Adds $17M To Advance Clinical Trial Recruitment Software
Deep 6 AI Adds $17M To Advance Clinical Trial Recruitment Software
Xconomy
software
artificial intelligence
Deep 6 AI
patients
clinical trials
clinical trial recruitment
Flag link:
Mereo’s brittle bone drug likely to shrug off phase 2b fail, say analysts
Mereo’s brittle bone drug likely to shrug off phase 2b fail, say analysts
Pharmaforum
Mereo BioPharma
clinical trials
brittle bone disease
setrusumab
Flag link:
Here’s Why Aurinia Pharmaceuticals Stock Jumped Higher Today
Here’s Why Aurinia Pharmaceuticals Stock Jumped Higher Today
Motley Fool
Aurinia Pharmaceuticals
clinical trials
voclosporin
lupus nephritis
Flag link:
ChemoCentryx Drug Hits Co-Primary Endpoints in Phase III Vasculitis Trial
ChemoCentryx Drug Hits Co-Primary Endpoints in Phase III Vasculitis Trial
BioSpace
ChemoCentryx
Vifor Fresenius Medical Care Renal Pharma
avacopan
ANCA-positive vasculitis
clinical trials
Flag link:

Pages